author-photo

Norihiro Watanabe

Center for Cell and Gene Therapy

20

Papers

496

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Evaluation of cyclin A1–specific T cells as a potential treatment for acute myeloid leukemia

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (2)
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment.

2020 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (8)
Engineered off-the-shelf therapeutic T cells resist host immune rejection

2020 Nature Biotechnology
Show All
- Source
- Cite
- Save
Citations (25)
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
Enhancing the potency and specificity of engineered T cells for cancer treatment

2018 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (58)
Engineered CAR T cell therapy for solid tumors

2018
Show All
- Source
- Cite
- Save
Citations (0)
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

2017 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (136)
751. Improving CAR T Cell Function by Reversing the Immunosuppressive Tumor Environment of Pancreatic Cancer

2016 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (0)